Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

03124

Sigma-Aldrich

Iodure de potassium

puriss., meets analytical specification of Ph. Eur. BP, USP, 99.0-100.5% (calc. to the dried substance)

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule linéaire :
KI
Numéro CAS:
7681-11-0
Poids moléculaire :
166.00
Numéro CE :
231-659-4
Numéro MDL:
MFCD00011405
Code UNSPSC :
12352302
ID de substance PubChem :
329747559
Nomenclature NACRES :
NA.21

Pression de vapeur

1 mmHg ( 745 °C)

Niveau de qualité

200

Qualité

puriss.
meets analytical specification of Ph. Eur. BP, USP

Pureté

99.0-100.5% (calc. to the dried substance)

Forme

solid

Impuretés

ammonium, in accordance
 organic volatile impurities, complies (GC)
 residual solvents, in accordance
≤0.001% heavy metals (as Pb)
≤0.01% thiosulfate (S2O3)
≤0.02% free alkali (as KOH)

Perte

≤0.5% loss on drying, 105 °C

pH

~6.9 (20 °C, 50 g/L)

Pf

681 °C (lit.)

Traces d'anions

iodate (IO3-): in accordance
nitrate (NO3-): in accordance
nitrite (NO2-): in accordance
sulfate (SO42-): ≤100 mg/kg

Traces de cations

Ba:, in accordance
Fe: ≤10 mg/kg

Adéquation

complies for appearance of solution

Chaîne SMILES 

[K+].[I-]

InChI

1S/HI.K/h1H;/q;+1/p-1

Clé InChI

NLKNQRATVPKPDG-UHFFFAOYSA-M

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Description générale

Potassium iodide (KI) is an inorganic potassium salt. Alumina loaded with potassium iodide has been employed as catalyst for the transesterification of soybean oil with methanol. Influence of KI on the in vitro generation of polymorphonudear leukocyte (PMN)-derived oxygen intermediates has been investigated.

Application

Potassium iodide (KI) was used in the preparation of standard iodide stock solution for the determination of iodide by size exclusion chromatography. It may be used in the spectrophotometric determination of advanced oxidation protein products (AOPP).

Pictogrammes

Health hazard
GHS08

Mention d'avertissement

Danger

Mentions de danger

H372

Classification des risques

STOT RE 1 Oral

Organes cibles

Thyroid

Code de la classe de stockage

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

Classe de danger pour l'eau (WGK)

WGK 3

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Y Miyachi et al.
The British journal of dermatology, 107(2), 209-214 (1982-08-01)
The effects of potassium iodide, colchicine and dapsone on the in vitro generation of polymorphonuclear leukocyte (PMN)-derived oxygen intermediates were investigated. These three drugs have beneficial effects on those conditions in which PMNs play an important pathogenetic role. Three oxygen
Alumina-supported potassium iodide as a heterogeneous catalyst for biodiesel production from soybean oil.
Xie W and Li H.
J. Mol. Catal. A: Chem., 255(1), 1-9 (2006)
V Witko-Sarsat et al.
Journal of immunology (Baltimore, Md. : 1950), 161(5), 2524-2532 (1998-09-02)
We previously demonstrated the presence of advanced oxidation protein products (AOPP), a novel marker of oxidative stress in the plasma of uremic patients receiving maintenance dialysis. The present study in a cohort of 162 uremic patients showed that plasma concentrations
H B Li et al.
Journal of chromatography. A, 918(2), 335-339 (2001-06-16)
A novel method for the determination of iodide by size exclusion chromatography was established. The method was simple and highly sensitive with good precision. Iodide was converted to iodine, then sequestered with starch, and separated from the matrix using a
S C Clement et al.
Pediatric blood & cancer, 60(11), 1833-1838 (2013-07-09)
Thyroid dysfunction has been reported in up to 52% of patients 1.4 years after treatment with (131) I-Metaiodobenzylguanidine (MIBG) in children with neuroblastoma (NBL), despite the use of potassium-iodide (KI). Our aim was to investigate if the incidence and severity
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique